Pancreatic Cancer Research

ResearcherNational Institutes of HealthNo recent work listed

William Tristram Arscott

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0110-8569; OpenAlex author ID A5103092442. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 2

  1. Concurrent Nab-paclitaxel and Radiotherapy: Novel Radiosensitization for Borderline Resectable or Unresectable Pancreatic Cancer. Co-author DOI 10.1097/coc.0000000000000854↗
  2. EGFR isoforms in exosomes as a novel method for biomarker discovery in pancreatic cancer. Co-author DOI 10.2217/bmm.11.80↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jacob Ezra Shabason · 1 shared paper, 2021 · strength 0.11
  2. Adham Sean Bear · 1 shared paper, 2021 · strength 0.11
  3. John Peter Plastaras · 1 shared paper, 2021 · strength 0.11
  4. Edgar Ben‐Josef · 1 shared paper, 2021 · strength 0.11
  5. Jeffrey A. Drebin · 1 shared paper, 2021 · strength 0.11
  6. James M. Metz · 1 shared paper, 2021 · strength 0.11
  7. Mark H. O’Hara · 1 shared paper, 2021 · strength 0.11
  8. Stuti G. Shroff · 1 shared paper, 2021 · strength 0.11
  9. Kim A. Reiss · 1 shared paper, 2021 · strength 0.11
  10. Kevin A. Camphausen · 1 shared paper, 2011 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.